Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
To review the impact of collaborative studies on advances in the biology and treatment of acute lymphoblastic leukemia (ALL) in children and adolescents. A review of English literature on childhood ALL focusing on collaborative studies was performed. The resulting article was reviewed and revised by...
Uloženo v:
| Vydáno v: | Journal of clinical oncology Ročník 33; číslo 27; s. 2938 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
20.09.2015
|
| Témata: | |
| ISSN: | 1527-7755, 1527-7755 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | To review the impact of collaborative studies on advances in the biology and treatment of acute lymphoblastic leukemia (ALL) in children and adolescents.
A review of English literature on childhood ALL focusing on collaborative studies was performed. The resulting article was reviewed and revised by the committee chairs of the major ALL study groups.
With long-term survival rates for ALL approaching 90% and the advent of high-resolution genome-wide analyses, several international study groups or consortia were established to conduct collaborative research to further improve outcome. As a result, treatment strategies have been improved for several subtypes of ALL, such as infant, MLL-rearranged, Philadelphia chromosome-positive, and Philadelphia chromosome-like ALL. Many recurrent genetic abnormalities that respond to tyrosine kinase inhibitors and multiple genetic determinants of drug resistance and toxicities have been identified to help develop targeted therapy. Several genetic polymorphisms have been recognized that show susceptibility to developing ALL and that help explain the racial/ethnic differences in the incidence of ALL.
The information gained from collaborative studies has helped decipher the heterogeneity of ALL to help improve personalized treatment, which will further advance the current high cure rate and the quality of life for children and adolescents with ALL. |
|---|---|
| AbstractList | To review the impact of collaborative studies on advances in the biology and treatment of acute lymphoblastic leukemia (ALL) in children and adolescents.
A review of English literature on childhood ALL focusing on collaborative studies was performed. The resulting article was reviewed and revised by the committee chairs of the major ALL study groups.
With long-term survival rates for ALL approaching 90% and the advent of high-resolution genome-wide analyses, several international study groups or consortia were established to conduct collaborative research to further improve outcome. As a result, treatment strategies have been improved for several subtypes of ALL, such as infant, MLL-rearranged, Philadelphia chromosome-positive, and Philadelphia chromosome-like ALL. Many recurrent genetic abnormalities that respond to tyrosine kinase inhibitors and multiple genetic determinants of drug resistance and toxicities have been identified to help develop targeted therapy. Several genetic polymorphisms have been recognized that show susceptibility to developing ALL and that help explain the racial/ethnic differences in the incidence of ALL.
The information gained from collaborative studies has helped decipher the heterogeneity of ALL to help improve personalized treatment, which will further advance the current high cure rate and the quality of life for children and adolescents with ALL. To review the impact of collaborative studies on advances in the biology and treatment of acute lymphoblastic leukemia (ALL) in children and adolescents.PURPOSETo review the impact of collaborative studies on advances in the biology and treatment of acute lymphoblastic leukemia (ALL) in children and adolescents.A review of English literature on childhood ALL focusing on collaborative studies was performed. The resulting article was reviewed and revised by the committee chairs of the major ALL study groups.METHODSA review of English literature on childhood ALL focusing on collaborative studies was performed. The resulting article was reviewed and revised by the committee chairs of the major ALL study groups.With long-term survival rates for ALL approaching 90% and the advent of high-resolution genome-wide analyses, several international study groups or consortia were established to conduct collaborative research to further improve outcome. As a result, treatment strategies have been improved for several subtypes of ALL, such as infant, MLL-rearranged, Philadelphia chromosome-positive, and Philadelphia chromosome-like ALL. Many recurrent genetic abnormalities that respond to tyrosine kinase inhibitors and multiple genetic determinants of drug resistance and toxicities have been identified to help develop targeted therapy. Several genetic polymorphisms have been recognized that show susceptibility to developing ALL and that help explain the racial/ethnic differences in the incidence of ALL.RESULTSWith long-term survival rates for ALL approaching 90% and the advent of high-resolution genome-wide analyses, several international study groups or consortia were established to conduct collaborative research to further improve outcome. As a result, treatment strategies have been improved for several subtypes of ALL, such as infant, MLL-rearranged, Philadelphia chromosome-positive, and Philadelphia chromosome-like ALL. Many recurrent genetic abnormalities that respond to tyrosine kinase inhibitors and multiple genetic determinants of drug resistance and toxicities have been identified to help develop targeted therapy. Several genetic polymorphisms have been recognized that show susceptibility to developing ALL and that help explain the racial/ethnic differences in the incidence of ALL.The information gained from collaborative studies has helped decipher the heterogeneity of ALL to help improve personalized treatment, which will further advance the current high cure rate and the quality of life for children and adolescents with ALL.CONCLUSIONThe information gained from collaborative studies has helped decipher the heterogeneity of ALL to help improve personalized treatment, which will further advance the current high cure rate and the quality of life for children and adolescents with ALL. |
| Author | Downing, James R Escherich, Gabriele Relling, Mary V Benoit, Yves C M Biondi, Andrea Vora, Ajay Pui, Ching-Hon Evans, William E Schrappe, Martin Izraeli, Shai Pieters, Rob Horibe, Keizo Baruchel, André Yang, Jun J Yeoh, Allen Eng Juh Schmiegelow, Kjeld Hunger, Stephen P Silverman, Lewis B Liang, Der-Cherng Mullighan, Charles G |
| Author_xml | – sequence: 1 givenname: Ching-Hon surname: Pui fullname: Pui, Ching-Hon email: ching-hon.pui@stjude.org organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan. ching-hon.pui@stjude.org – sequence: 2 givenname: Jun J surname: Yang fullname: Yang, Jun J organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 3 givenname: Stephen P surname: Hunger fullname: Hunger, Stephen P organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 4 givenname: Rob surname: Pieters fullname: Pieters, Rob organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 5 givenname: Martin surname: Schrappe fullname: Schrappe, Martin organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 6 givenname: Andrea surname: Biondi fullname: Biondi, Andrea organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 7 givenname: Ajay surname: Vora fullname: Vora, Ajay organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 8 givenname: André surname: Baruchel fullname: Baruchel, André organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 9 givenname: Lewis B surname: Silverman fullname: Silverman, Lewis B organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 10 givenname: Kjeld surname: Schmiegelow fullname: Schmiegelow, Kjeld organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 11 givenname: Gabriele surname: Escherich fullname: Escherich, Gabriele organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 12 givenname: Keizo surname: Horibe fullname: Horibe, Keizo organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 13 givenname: Yves C M surname: Benoit fullname: Benoit, Yves C M organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 14 givenname: Shai surname: Izraeli fullname: Izraeli, Shai organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 15 givenname: Allen Eng Juh surname: Yeoh fullname: Yeoh, Allen Eng Juh organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 16 givenname: Der-Cherng surname: Liang fullname: Liang, Der-Cherng organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 17 givenname: James R surname: Downing fullname: Downing, James R organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 18 givenname: William E surname: Evans fullname: Evans, William E organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 19 givenname: Mary V surname: Relling fullname: Relling, Mary V organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan – sequence: 20 givenname: Charles G surname: Mullighan fullname: Mullighan, Charles G organization: Ching-Hon Pui, Jun J. Yang, James R. Downing, Williams E. Evans, Mary V. Relling, and Charles G. Mullighan, St Jude Children's Research Hospital and the University of Tennessee Health Science Center, Memphis, TN; Stephen P. Hunger, University of Colorado School of Medicine and the University of Colorado Cancer Center and Children's Hospital Colorado, Aurora, CO; Rob Pieters, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Martin Schrappe, University Medical Center Schleswig-Holstein, Christian-Albrechts-University, Kiel; Gabriele Escherich, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany; Andrea Biondi, Clinica Pediatrica and Centro Ricerca Tettamanti, Università di Milano-Bicocca, Monza, Italy; Ajay Vora, Children's Cancer Group, School of Cancer, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom; André Baruchel, Hôpital Robert Debré and University of Paris Diderot, Paris, France; Lewis B. Silverman, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA; Kjeld Schmiegelow, Institute of Clinical Medicine, University of Copenhagen and Juliane Marie Centre, the University Hospital Rigshospitalet, Copenhagen, Denmark; Keizo Horibe, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan; Yves C.M. Benoit, Universiteit Gent, Gent, Belgium; Shai Izraeli, Chaim Sheba Medical Center and Sackler Medical School, Tel Aviv University, Tel Aviv, Israel; Allen Eng Juh Yeoh, Yong Loo Lin School of Medicine and Cancer Science Institute, National University of Singapore, and Viva-University Children's Cancer Centre, National University Hospital, Singapore; and Der-Cherng Liang, Mackay Memorial Hospital, Taipei, Taiwan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26304874$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj7tPwzAYxC1URB-wM6GMLAl-O2arIspDkcpQ5sixnSaQxMFOhv73RKJILHefTj-dvluDRe96C8AtggnCED68ZfsEQ0QTJhPECb8AK8SwiIVgbPHvXoJ1CJ9wJlPCrsAScwJpKugK7LK6aU3tnIm2ehptlJ-6oXZlq8LY6Ci305ftGvUYvXt39DaE6FB7Nx3rKHNtq0rn1di4_hpcVqoN9ubsG_CxezpkL3G-f37NtnmsKcdjTKyEZYqoJorjlCHNtTJGKV1RY0ipmJBzhFNUimoWWVFpKqYsJKkgiGm8Afe_vYN335MNY9E1Qdv5k966KRRIICIZJlLM6N0ZncrOmmLwTaf8qfjbjn8AlHJdzA |
| CitedBy_id | crossref_primary_10_3324_haematol_2023_283815 crossref_primary_10_1007_s00520_022_07566_6 crossref_primary_10_1097_MPH_0000000000002533 crossref_primary_10_3390_jcm8020207 crossref_primary_10_1111_cas_14238 crossref_primary_10_1016_j_semcancer_2017_09_001 crossref_primary_10_1111_ppe_12895 crossref_primary_10_1007_s00256_020_03513_w crossref_primary_10_1182_bloodadvances_2022006965 crossref_primary_10_1002_pbc_31886 crossref_primary_10_1038_s41416_021_01332_x crossref_primary_10_1038_s41467_024_49944_0 crossref_primary_10_1016_j_leukres_2022_106925 crossref_primary_10_1002_ajh_24629 crossref_primary_10_1002_pbc_30683 crossref_primary_10_1002_cncr_33106 crossref_primary_10_1007_s12185_023_03701_z crossref_primary_10_1016_S1470_2045_15_00538_0 crossref_primary_10_1097_MPH_0000000000002305 crossref_primary_10_1007_s12098_023_04687_6 crossref_primary_10_1038_s41375_018_0226_6 crossref_primary_10_1002_pbc_31997 crossref_primary_10_1182_blood_2017_10_812933 crossref_primary_10_1038_s41375_020_01024_0 crossref_primary_10_1016_j_micres_2018_01_011 crossref_primary_10_1177_107327481602300414 crossref_primary_10_1016_j_clml_2019_06_011 crossref_primary_10_3390_cancers13081847 crossref_primary_10_1002_pbc_26291 crossref_primary_10_1016_j_ejcped_2023_100133 crossref_primary_10_1002_pbc_29563 crossref_primary_10_1038_s41408_024_01180_x crossref_primary_10_1007_s12672_024_00869_6 crossref_primary_10_3389_fimmu_2022_847008 crossref_primary_10_1016_j_medcle_2019_09_004 crossref_primary_10_3390_cancers16183208 crossref_primary_10_1002_pbc_29203 crossref_primary_10_1200_JGO_19_00010 crossref_primary_10_1007_s12325_021_01767_x crossref_primary_10_1182_blood_2023022050 crossref_primary_10_1182_blood_2017_03_771162 crossref_primary_10_1200_JCO_2018_77_7250 crossref_primary_10_1016_j_cegh_2021_100932 crossref_primary_10_1080_10428194_2016_1219904 crossref_primary_10_1097_MPH_0000000000002995 crossref_primary_10_1097_MPH_0000000000002999 crossref_primary_10_1002_pbc_31988 crossref_primary_10_1111_bjh_15761 crossref_primary_10_3389_fped_2025_1530832 crossref_primary_10_1016_j_blre_2020_100677 crossref_primary_10_1016_j_exphem_2018_07_002 crossref_primary_10_1002_cnr2_1533 crossref_primary_10_1016_j_lanwpc_2023_100818 crossref_primary_10_1055_a_1331_5396 crossref_primary_10_3390_jof7030186 crossref_primary_10_12688_f1000research_10768_1 crossref_primary_10_1002_pbc_27496 crossref_primary_10_1093_jnci_djac095 crossref_primary_10_1002_cncr_32596 crossref_primary_10_1182_blood_2017_11_817510 crossref_primary_10_1080_17474086_2024_2370559 crossref_primary_10_3390_cancers15102812 crossref_primary_10_3390_genes12101632 crossref_primary_10_1053_j_jvca_2020_02_052 crossref_primary_10_3390_ijms21103409 crossref_primary_10_1097_MPH_0000000000002645 crossref_primary_10_1016_j_acra_2019_04_010 crossref_primary_10_1038_s41598_024_79733_0 crossref_primary_10_1002_ijc_32942 crossref_primary_10_1182_blood_2019003801 crossref_primary_10_1016_j_biopha_2022_113000 crossref_primary_10_1016_j_clml_2020_09_009 crossref_primary_10_3390_ijms26031076 crossref_primary_10_3390_jpm12060881 crossref_primary_10_1186_s12913_022_08201_0 crossref_primary_10_1200_JGO_17_00095 crossref_primary_10_4155_ipk_2016_0022 crossref_primary_10_3390_genes13071240 crossref_primary_10_1002_pbc_26393 crossref_primary_10_1200_JCO_2016_67_5066 crossref_primary_10_1002_pbc_28334 crossref_primary_10_1101_gr_209163_116 crossref_primary_10_3389_fphar_2019_01100 crossref_primary_10_7759_cureus_32921 crossref_primary_10_1111_tri_13058 crossref_primary_10_3390_biomedicines11102693 crossref_primary_10_2217_pgs_2017_0164 crossref_primary_10_3390_ijms22030988 crossref_primary_10_1038_s41375_020_0793_1 crossref_primary_10_3389_fimmu_2022_915590 crossref_primary_10_1093_humrep_dex082 crossref_primary_10_1080_01635581_2018_1516792 crossref_primary_10_1038_s41379_019_0423_5 crossref_primary_10_3390_children11111329 crossref_primary_10_1016_j_canep_2016_03_015 crossref_primary_10_3389_fonc_2020_557643 crossref_primary_10_1016_j_ccell_2018_07_007 crossref_primary_10_1002_pbc_30881 crossref_primary_10_1002_pbc_26142 crossref_primary_10_1200_JCO_19_00889 crossref_primary_10_1111_ped_13457 crossref_primary_10_1038_s41514_025_00233_0 crossref_primary_10_3390_cancers14133088 crossref_primary_10_1002_pbc_28322 crossref_primary_10_1016_j_mjafi_2024_04_017 crossref_primary_10_1002_cncr_31085 crossref_primary_10_1182_bloodadvances_2018025718 crossref_primary_10_1002_pbc_29899 crossref_primary_10_3390_cancers13225653 crossref_primary_10_1002_pbc_29658 crossref_primary_10_1055_s_0041_1731972 crossref_primary_10_3389_fped_2021_784024 crossref_primary_10_1080_10428194_2020_1786557 crossref_primary_10_1038_s41416_021_01374_1 crossref_primary_10_1038_s41598_020_80613_6 crossref_primary_10_1038_s41698_025_00887_9 crossref_primary_10_1186_s13039_019_0454_0 crossref_primary_10_1016_j_ejon_2022_102141 crossref_primary_10_1111_cas_15239 crossref_primary_10_1016_j_clml_2022_12_009 crossref_primary_10_1111_bjh_70067 crossref_primary_10_1038_s41419_020_2388_1 crossref_primary_10_1182_bloodadvances_2019000051 crossref_primary_10_1002_pbc_26136 crossref_primary_10_1080_08880018_2022_2089791 crossref_primary_10_1016_j_labinv_2025_104241 crossref_primary_10_1007_s00432_016_2174_8 crossref_primary_10_1016_j_tranon_2024_102127 crossref_primary_10_1080_14796694_2025_2556647 crossref_primary_10_1200_EDBK_25_473298 crossref_primary_10_1111_bjh_14874 crossref_primary_10_1136_bmjopen_2022_070804 crossref_primary_10_3389_fped_2025_1644720 crossref_primary_10_3390_biomedicines13071626 crossref_primary_10_1038_s41598_020_71468_y crossref_primary_10_1080_17482631_2024_2310147 crossref_primary_10_1002_cam4_2082 crossref_primary_10_3390_cancers12030723 crossref_primary_10_1016_j_canlet_2020_11_015 crossref_primary_10_1002_pbc_26002 crossref_primary_10_1016_j_semcancer_2020_10_013 crossref_primary_10_1124_jpet_122_001155 crossref_primary_10_1002_pbc_26489 crossref_primary_10_1002_cncr_33362 crossref_primary_10_1097_MD_0000000000020009 crossref_primary_10_1038_s41419_024_07040_7 crossref_primary_10_1097_MPH_0000000000002722 crossref_primary_10_1111_ijlh_13085 crossref_primary_10_1097_MS9_0000000000002863 crossref_primary_10_1038_s41598_023_27720_2 crossref_primary_10_1007_s11912_019_0861_8 crossref_primary_10_1177_27527530251337037 crossref_primary_10_1002_rth2_12182 crossref_primary_10_1186_s12885_022_10072_x crossref_primary_10_1186_s12887_020_02287_3 crossref_primary_10_7717_peerj_9337 crossref_primary_10_1097_MD_0000000000020115 crossref_primary_10_1002_pbc_27683 crossref_primary_10_1007_s12094_023_03251_0 crossref_primary_10_1007_s12288_018_0997_y crossref_primary_10_1002_pbc_28894 crossref_primary_10_1002_pbc_29986 crossref_primary_10_1200_JCO_2015_63_4535 crossref_primary_10_3389_fonc_2024_1456004 crossref_primary_10_1158_2159_8290_CD_21_0258 crossref_primary_10_1136_bmjopen_2020_045543 crossref_primary_10_1016_S1470_2045_15_00440_4 crossref_primary_10_1038_nm_4441 crossref_primary_10_1097_MOP_0000000000000729 crossref_primary_10_1182_blood_2019004043 crossref_primary_10_3390_children9111740 crossref_primary_10_1097_MPH_0000000000002494 crossref_primary_10_3390_jcm10204728 crossref_primary_10_1097_MPH_0000000000002377 crossref_primary_10_1016_j_phoj_2025_100461 crossref_primary_10_1182_bloodadvances_2017007286 crossref_primary_10_1007_s00277_023_05285_4 crossref_primary_10_31083_j_fbl2702039 crossref_primary_10_1016_j_clml_2025_05_004 crossref_primary_10_1016_j_jtct_2025_01_003 crossref_primary_10_1016_j_oraloncology_2024_107103 crossref_primary_10_1016_j_bbmt_2020_07_028 crossref_primary_10_3390_cancers13246313 crossref_primary_10_1182_blood_2021012328 crossref_primary_10_1016_j_canep_2020_101838 crossref_primary_10_1038_s41375_021_01460_6 crossref_primary_10_62347_QFMM6731 crossref_primary_10_1007_s00280_022_04482_8 crossref_primary_10_3389_fpubh_2022_910641 crossref_primary_10_1186_s13148_024_01662_6 crossref_primary_10_1080_10428194_2025_2526795 crossref_primary_10_3389_fgene_2022_1058468 crossref_primary_10_1002_cam4_3249 crossref_primary_10_1016_j_therap_2021_12_003 crossref_primary_10_1016_j_bjid_2023_102745 crossref_primary_10_1159_000531480 crossref_primary_10_1007_s00277_023_05250_1 crossref_primary_10_1186_s12864_024_10975_y crossref_primary_10_3390_genes12091355 crossref_primary_10_1097_FPC_0000000000000245 crossref_primary_10_3390_ijms22136718 crossref_primary_10_1002_pbc_30154 crossref_primary_10_3324_haematol_2024_286783 crossref_primary_10_1080_08880018_2016_1276235 crossref_primary_10_1002_pbc_29169 crossref_primary_10_1016_j_cll_2022_05_007 crossref_primary_10_1182_blood_2015_09_671131 crossref_primary_10_1002_cncr_33175 crossref_primary_10_1016_j_biopha_2019_108913 crossref_primary_10_1093_jjco_hyy071 crossref_primary_10_1097_MOG_0000000000000865 crossref_primary_10_1080_10428194_2020_1864361 crossref_primary_10_1007_s41669_023_00411_4 crossref_primary_10_1080_0284186X_2021_1900908 crossref_primary_10_1007_s00285_019_01404_w crossref_primary_10_3390_cancers13010017 crossref_primary_10_1016_j_pedn_2019_02_007 crossref_primary_10_1093_jncics_pkae046 crossref_primary_10_1182_blood_2017_09_806521 crossref_primary_10_3390_ijms26146919 crossref_primary_10_1080_15384047_2025_2460252 crossref_primary_10_1002_cam4_70596 crossref_primary_10_1016_S0140_6736_25_00864_5 crossref_primary_10_3389_fonc_2020_01672 crossref_primary_10_1182_blood_2019000813 crossref_primary_10_1080_07853890_2018_1564359 crossref_primary_10_1002_ijc_34720 crossref_primary_10_1016_S1470_2045_16_30035_3 crossref_primary_10_1007_s11033_021_06572_x crossref_primary_10_1097_MOP_0000000000000853 crossref_primary_10_1080_10428194_2025_2456100 crossref_primary_10_1016_j_leukres_2020_106316 crossref_primary_10_17116_rosrino202331041265 crossref_primary_10_3389_fgene_2020_00598 crossref_primary_10_3390_jcm11092489 crossref_primary_10_1002_jbmr_4870 crossref_primary_10_1016_j_ebiom_2024_105171 crossref_primary_10_1055_s_0040_1722282 crossref_primary_10_1002_ajh_27708 crossref_primary_10_1016_j_modpat_2025_100741 crossref_primary_10_1007_s00262_017_2070_3 crossref_primary_10_1182_blood_2018_01_785840 crossref_primary_10_1002_cncr_31099 crossref_primary_10_1002_pon_5654 crossref_primary_10_1016_j_ejca_2024_114338 crossref_primary_10_2147_OTT_S366625 crossref_primary_10_1007_s12185_018_2518_z crossref_primary_10_1016_j_leukres_2018_01_012 crossref_primary_10_1002_ijc_33529 crossref_primary_10_3390_jpm10030137 crossref_primary_10_1016_j_ejca_2025_115445 crossref_primary_10_1097_MPH_0000000000001007 crossref_primary_10_1200_JCO_19_01692 crossref_primary_10_3389_fped_2023_1155449 crossref_primary_10_3322_caac_21665 crossref_primary_10_1002_path_5924 crossref_primary_10_1016_j_immuni_2019_12_011 crossref_primary_10_1002_cpt_629 crossref_primary_10_3389_fonc_2021_632231 crossref_primary_10_1182_blood_2017_03_735654 crossref_primary_10_1007_s44313_025_00085_3 crossref_primary_10_1016_j_canep_2021_102040 crossref_primary_10_1080_10428194_2018_1538507 crossref_primary_10_1002_cpt_985 crossref_primary_10_1007_s11239_020_02346_7 crossref_primary_10_1182_blood_2020006164 crossref_primary_10_1111_petr_13408 crossref_primary_10_1002_jha2_27 crossref_primary_10_3389_fimmu_2019_02856 crossref_primary_10_1080_14656566_2021_1931683 crossref_primary_10_1093_jncics_pkab069 crossref_primary_10_1016_S2352_4642_18_30066_X crossref_primary_10_1186_s13046_019_1280_2 crossref_primary_10_1158_1078_0432_CCR_19_0551 crossref_primary_10_1016_j_lfs_2019_116931 crossref_primary_10_1038_s41375_024_02474_6 crossref_primary_10_1038_bjc_2017_462 crossref_primary_10_1097_MPH_0000000000001015 crossref_primary_10_1182_blood_2020008471 crossref_primary_10_1097_JCMA_0000000000000038 crossref_primary_10_1111_ijlh_14551 crossref_primary_10_1111_jhn_13273 crossref_primary_10_2217_ijh_2016_0009 crossref_primary_10_1016_j_jaut_2017_08_003 crossref_primary_10_1038_s41588_021_00993_x crossref_primary_10_1111_bjh_20007 crossref_primary_10_1097_MPH_0000000000002344 crossref_primary_10_1186_s13063_022_06033_1 crossref_primary_10_1182_blood_2017_05_782086 crossref_primary_10_1002_kjm2_12061 crossref_primary_10_1111_cas_14792 crossref_primary_10_1002_cnr2_1703 crossref_primary_10_1097_HS9_0000000000000018 crossref_primary_10_1016_j_leukres_2016_07_009 crossref_primary_10_1016_j_jpainsymman_2020_08_030 crossref_primary_10_1182_bloodadvances_2021006152 crossref_primary_10_1002_cpt_3501 crossref_primary_10_5812_ijcm_105920 crossref_primary_10_1002_cpt_2894 crossref_primary_10_1158_2159_8290_CD_21_0551 crossref_primary_10_3390_diagnostics13172748 crossref_primary_10_3390_cancers17152500 crossref_primary_10_1093_humrep_deab236 crossref_primary_10_1080_10428194_2024_2362408 crossref_primary_10_3389_fonc_2023_1255555 crossref_primary_10_1182_bloodadvances_2022008893 crossref_primary_10_1002_gcc_22882 crossref_primary_10_1111_scs_12739 crossref_primary_10_1016_j_pec_2021_04_015 crossref_primary_10_1016_j_ejca_2021_08_001 crossref_primary_10_1080_10428194_2024_2350665 crossref_primary_10_1016_j_ejcped_2023_100020 crossref_primary_10_1016_j_bbmt_2020_04_003 crossref_primary_10_1038_s41556_021_00814_7 crossref_primary_10_1002_pbc_28024 crossref_primary_10_1002_pbc_28388 crossref_primary_10_1007_s12185_020_02907_9 crossref_primary_10_1080_10428194_2022_2123224 crossref_primary_10_1038_s41375_022_01693_z crossref_primary_10_24287_1726_1708_2022_21_3_28_41 crossref_primary_10_1016_j_phoj_2025_100480 crossref_primary_10_1002_cai2_67 crossref_primary_10_1038_s41416_020_0824_8 crossref_primary_10_1097_MPH_0000000000002205 crossref_primary_10_1002_gcc_22416 crossref_primary_10_1080_08880018_2019_1658834 crossref_primary_10_1016_j_medcli_2019_09_011 crossref_primary_10_2217_epi_2017_0138 crossref_primary_10_1111_bjh_18147 crossref_primary_10_1080_17460441_2016_1237939 crossref_primary_10_3389_fcell_2021_695225 crossref_primary_10_1002_hem3_70025 crossref_primary_10_3389_fonc_2022_1062065 crossref_primary_10_1002_pbc_30684 crossref_primary_10_1007_s43441_022_00410_3 crossref_primary_10_1016_j_medcle_2017_06_039 crossref_primary_10_1182_blood_2019004090 crossref_primary_10_2217_fon_2016_0261 crossref_primary_10_1002_pbc_29582 crossref_primary_10_3390_cancers16091667 crossref_primary_10_1002_pbc_27286 crossref_primary_10_3389_fphar_2016_00491 crossref_primary_10_1016_j_exphem_2018_10_001 crossref_primary_10_1080_10428194_2017_1280605 crossref_primary_10_1016_j_leukres_2024_107560 crossref_primary_10_1016_j_beha_2022_101403 crossref_primary_10_1038_s43018_020_00167_4 crossref_primary_10_1016_j_leukres_2019_106228 crossref_primary_10_1002_pbc_26738 crossref_primary_10_1007_s12288_019_01144_3 crossref_primary_10_1007_s00467_016_3461_y crossref_primary_10_1016_j_ejca_2021_04_006 crossref_primary_10_1158_0008_5472_CAN_19_1941 crossref_primary_10_1111_bjh_19223 crossref_primary_10_3324_haematol_2023_284228 crossref_primary_10_1016_j_canlet_2017_08_034 crossref_primary_10_1111_bjh_17163 crossref_primary_10_1111_bjh_17162 crossref_primary_10_1186_s13046_018_0859_3 crossref_primary_10_1016_j_xphs_2021_02_025 crossref_primary_10_1016_j_ejcped_2025_100243 crossref_primary_10_1038_s42003_021_02330_8 crossref_primary_10_1016_j_exphem_2025_104771 crossref_primary_10_3389_fonc_2022_1022979 crossref_primary_10_1080_2162402X_2017_1341032 crossref_primary_10_1177_10434542211040203 crossref_primary_10_2478_amb_2023_0009 crossref_primary_10_1097_COC_0000000000001179 crossref_primary_10_1182_blood_2016_12_758979 crossref_primary_10_1002_pbc_28907 crossref_primary_10_1002_cam4_2438 crossref_primary_10_1200_JCO_2017_74_3617 crossref_primary_10_1097_MPH_0000000000000921 crossref_primary_10_1016_j_jpainsymman_2016_11_013 crossref_primary_10_1200_JCO_2016_69_6278 crossref_primary_10_3390_cancers16244241 crossref_primary_10_1038_s41375_024_02166_1 crossref_primary_10_1182_blood_2023020678 crossref_primary_10_1080_10428194_2017_1386305 crossref_primary_10_1182_blood_2018_10_881961 crossref_primary_10_3390_pathogens11101091 crossref_primary_10_1002_wsbm_1509 crossref_primary_10_1038_s43018_024_00864_4 crossref_primary_10_3389_fcell_2019_00040 crossref_primary_10_1080_10428194_2019_1605071 crossref_primary_10_1007_s40262_019_00803_y crossref_primary_10_1200_JCO_2017_76_7228 crossref_primary_10_1002_ijc_34556 crossref_primary_10_1007_s11864_020_00757_5 crossref_primary_10_3390_cells10123349 crossref_primary_10_1186_s13062_016_0154_1 crossref_primary_10_3389_fgene_2020_00886 crossref_primary_10_1016_j_ctarc_2020_100279 crossref_primary_10_1016_j_ejca_2020_10_010 crossref_primary_10_1038_s41375_018_0361_0 crossref_primary_10_3389_fped_2022_1100404 crossref_primary_10_3389_fonc_2022_841179 crossref_primary_10_1007_s13312_024_3293_y crossref_primary_10_1016_j_bbrc_2023_09_023 crossref_primary_10_7759_cureus_73727 crossref_primary_10_1182_blood_2016_12_725804 crossref_primary_10_1002_pbc_25876 crossref_primary_10_1038_s41598_021_00227_4 crossref_primary_10_1016_j_jconrel_2016_07_035 crossref_primary_10_3390_diagnostics13091589 crossref_primary_10_1002_ijc_32269 crossref_primary_10_1007_s12185_017_2289_y crossref_primary_10_3390_cancers12123498 crossref_primary_10_1186_s12874_019_0725_9 crossref_primary_10_1136_archdischild_2018_316181 crossref_primary_10_1038_s41598_020_75860_6 crossref_primary_10_3389_fonc_2023_1246924 crossref_primary_10_23736_S0394_3410_19_03908_0 crossref_primary_10_1002_ajh_25124 crossref_primary_10_1111_cas_13834 crossref_primary_10_3390_lymphatics1010005 crossref_primary_10_3390_ijms21176251 crossref_primary_10_1007_s00277_018_3292_y crossref_primary_10_1097_HS9_0000000000000875 crossref_primary_10_7759_cureus_89172 crossref_primary_10_1038_s41598_020_59214_w crossref_primary_10_1182_bloodadvances_2019000796 crossref_primary_10_3389_fped_2022_828702 crossref_primary_10_1016_j_blre_2016_09_001 crossref_primary_10_1002_pbc_27904 crossref_primary_10_1007_s00132_022_04301_1 crossref_primary_10_1001_jama_2021_1395 crossref_primary_10_1136_jitc_2019_000148 crossref_primary_10_3389_fonc_2023_1207695 crossref_primary_10_1371_journal_pone_0231209 crossref_primary_10_1038_s41571_022_00607_3 crossref_primary_10_1200_JCO_2017_75_5215 crossref_primary_10_3390_cancers16101836 crossref_primary_10_1200_JCO_18_01877 crossref_primary_10_1080_08880018_2021_1906800 crossref_primary_10_1080_2162402X_2018_1448331 crossref_primary_10_1002_jcp_26510 crossref_primary_10_1080_17474086_2021_1967137 crossref_primary_10_2147_PHMT_S406181 crossref_primary_10_1158_1078_0432_CCR_18_3784 crossref_primary_10_1038_s41416_022_01796_5 crossref_primary_10_1172_JCI190443 crossref_primary_10_1002_cac2_12234 crossref_primary_10_3389_fgene_2022_856552 crossref_primary_10_1088_1742_6596_1294_6_062089 crossref_primary_10_1002_cam4_2757 crossref_primary_10_1002_pbc_26929 crossref_primary_10_1002_cam4_1307 crossref_primary_10_1038_bcj_2017_11 crossref_primary_10_1182_bloodadvances_2021005579 crossref_primary_10_1016_j_biopha_2021_111616 crossref_primary_10_1111_ijlh_13862 crossref_primary_10_1097_MPH_0000000000003037 crossref_primary_10_1002_cncr_31756 crossref_primary_10_1200_JCO_2017_76_0504 crossref_primary_10_3389_fresc_2023_1099516 crossref_primary_10_7759_cureus_49930 crossref_primary_10_1016_S1473_3099_18_30601_7 crossref_primary_10_3390_v13102001 crossref_primary_10_1007_s00761_016_0135_0 crossref_primary_10_1016_S1470_2045_21_00517_9 crossref_primary_10_1007_s12185_018_2423_5 crossref_primary_10_1007_s12185_024_03900_2 crossref_primary_10_1016_j_ebiom_2016_04_038 crossref_primary_10_1016_j_tranon_2024_101952 crossref_primary_10_1038_s41408_020_0287_4 crossref_primary_10_3390_lymphatics1020011 crossref_primary_10_1002_1878_0261_13276 crossref_primary_10_1038_s41598_020_69059_y crossref_primary_10_1002_cam4_2889 crossref_primary_10_1007_s12288_024_01734_w crossref_primary_10_3390_jcm10163556 crossref_primary_10_1007_s00277_021_04412_3 crossref_primary_10_1016_j_bneo_2025_100120 crossref_primary_10_1186_s12935_021_02335_7 crossref_primary_10_1002_jha2_488 crossref_primary_10_1002_cam4_71090 crossref_primary_10_3389_fped_2020_00509 crossref_primary_10_1182_blood_2020006583 crossref_primary_10_3389_fped_2019_00368 crossref_primary_10_3390_jpm10040244 crossref_primary_10_1200_JCO_18_00884 crossref_primary_10_1007_s12185_020_02981_z crossref_primary_10_1002_cncr_30899 crossref_primary_10_1002_pbc_31152 crossref_primary_10_1093_milmed_usac069 crossref_primary_10_3389_fonc_2021_639013 crossref_primary_10_1136_jitc_2022_004774 crossref_primary_10_3390_cancers14143303 crossref_primary_10_1038_s41375_024_02287_7 crossref_primary_10_1002_pbc_31018 crossref_primary_10_1016_j_beha_2021_101331 crossref_primary_10_1038_s41408_022_00613_9 crossref_primary_10_1158_1078_0432_CCR_16_2392 crossref_primary_10_3389_fonc_2024_1303421 crossref_primary_10_3390_biomedicines12040908 crossref_primary_10_1182_blood_2016_11_749507 crossref_primary_10_3390_children9050651 crossref_primary_10_1002_JLB_2MR0420_707R crossref_primary_10_1038_s41571_023_00802_w crossref_primary_10_1182_blood_2018_01_827949 crossref_primary_10_1016_j_arcped_2016_08_014 crossref_primary_10_1007_s11938_020_00311_0 crossref_primary_10_1186_s13046_022_02585_x crossref_primary_10_1016_S2352_3026_21_00136_8 crossref_primary_10_1182_blood_2022018653 crossref_primary_10_1097_CAD_0000000000000462 crossref_primary_10_1038_pr_2016_192 crossref_primary_10_3390_ijms22126371 crossref_primary_10_1038_s41698_021_00215_x crossref_primary_10_1080_08880018_2020_1825573 crossref_primary_10_1093_jnci_djy089 crossref_primary_10_1002_pbc_26222 crossref_primary_10_3389_fonc_2022_1082525 crossref_primary_10_1002_pbc_29852 crossref_primary_10_3389_fped_2022_797836 crossref_primary_10_3390_hematolrep16020035 crossref_primary_10_1186_s12967_018_1652_y crossref_primary_10_3390_cancers14133283 crossref_primary_10_1038_s41375_018_0039_7 crossref_primary_10_1016_j_biopha_2017_12_059 crossref_primary_10_1080_17568919_2025_2546774 crossref_primary_10_1093_labmed_lmz074 crossref_primary_10_1155_2018_5724686 crossref_primary_10_1186_s12889_024_21155_8 crossref_primary_10_1016_j_jmoldx_2022_08_001 crossref_primary_10_1172_JCI140797 crossref_primary_10_1097_MD_0000000000034965 crossref_primary_10_3389_fpubh_2022_918921 crossref_primary_10_1007_s12288_024_01787_x crossref_primary_10_1111_bjh_19610 crossref_primary_10_3390_ijms24087550 crossref_primary_10_1002_ijc_35231 crossref_primary_10_1056_NEJMoa2214171 crossref_primary_10_1002_cnr2_1107 crossref_primary_10_1016_j_bneo_2024_100015 crossref_primary_10_1073_pnas_2118529119 crossref_primary_10_1002_pbc_27300 crossref_primary_10_1002_pbc_29724 crossref_primary_10_1002_pbc_29829 crossref_primary_10_1080_10428194_2019_1641802 crossref_primary_10_1097_MPH_0000000000000971 crossref_primary_10_1111_bjh_18759 crossref_primary_10_1080_10428194_2025_2521650 crossref_primary_10_1111_bjh_15246 crossref_primary_10_1007_s11274_019_2612_2 crossref_primary_10_1055_s_0045_1811561 crossref_primary_10_1016_j_ejca_2017_09_030 crossref_primary_10_3390_children9091268 crossref_primary_10_3390_ijms24043860 crossref_primary_10_3324_haematol_2023_284409 crossref_primary_10_1007_s11523_024_01122_4 crossref_primary_10_1053_j_seminhematol_2020_09_001 crossref_primary_10_1007_s40272_017_0268_7 crossref_primary_10_1002_pbc_26686 crossref_primary_10_1186_s12885_025_14322_6 crossref_primary_10_1002_pbc_27898 crossref_primary_10_1007_s13337_021_00743_x crossref_primary_10_1111_bjh_16207 crossref_primary_10_1177_2040620720927575 crossref_primary_10_1002_pbc_29939 crossref_primary_10_1016_j_isci_2024_111356 crossref_primary_10_1200_JCO_2017_76_7871 crossref_primary_10_1038_s41408_020_0339_9 crossref_primary_10_1111_bjh_16329 crossref_primary_10_1186_s13045_021_01060_y crossref_primary_10_1016_j_bglo_2025_100011 crossref_primary_10_1016_j_ccell_2019_03_004 crossref_primary_10_1200_GO_21_00049 crossref_primary_10_1002_phar_2430 crossref_primary_10_3389_fimmu_2021_582539 crossref_primary_10_1182_blood_2024024283 crossref_primary_10_1002_ijc_35136 crossref_primary_10_1016_j_bbmt_2018_05_009 crossref_primary_10_1002_pbc_27761 crossref_primary_10_1007_s11136_018_1788_5 crossref_primary_10_1038_s41419_018_0625_7 crossref_primary_10_1002_pbc_27765 crossref_primary_10_1186_s12935_019_0834_x crossref_primary_10_1002_pbc_26436 crossref_primary_10_1002_pbc_26557 crossref_primary_10_1016_j_yexcr_2018_11_008 crossref_primary_10_3390_cancers17071238 crossref_primary_10_1016_j_compbiomed_2025_109831 crossref_primary_10_1080_08880018_2023_2168810 crossref_primary_10_1038_s41571_020_0411_1 crossref_primary_10_3389_fonc_2020_579673 crossref_primary_10_1007_s12288_020_01354_0 crossref_primary_10_1111_bjh_15580 crossref_primary_10_1200_JCO_18_00822 crossref_primary_10_1007_s00277_020_03953_3 crossref_primary_10_1007_s10555_019_09834_0 crossref_primary_10_1073_pnas_1814397115 crossref_primary_10_1182_blood_2020007932 crossref_primary_10_1182_bloodadvances_2021005631 crossref_primary_10_1007_s12185_020_03063_w crossref_primary_10_1016_S1470_2045_19_30031_2 crossref_primary_10_3390_ijms24054661 crossref_primary_10_1093_jnci_djz016 crossref_primary_10_17826_cumj_1559123 crossref_primary_10_3389_fonc_2025_1587185 crossref_primary_10_1007_s12032_025_02924_w crossref_primary_10_1038_leu_2017_265 crossref_primary_10_1002_hon_2799 crossref_primary_10_1007_s12253_017_0192_8 crossref_primary_10_1182_bloodadvances_2020003526 crossref_primary_10_1097_MPH_0000000000000843 crossref_primary_10_1016_j_ejphar_2019_172641 crossref_primary_10_3389_fped_2021_773895 crossref_primary_10_1002_pbc_26891 crossref_primary_10_1080_14656566_2017_1340938 crossref_primary_10_1182_blood_2020007702 crossref_primary_10_1007_s00431_017_2982_0 crossref_primary_10_1097_MPH_0000000000001939 crossref_primary_10_4155_bio_2021_0162 crossref_primary_10_1016_j_leukres_2018_07_001 crossref_primary_10_1007_s00520_023_08024_7 crossref_primary_10_1093_jnci_djy193 crossref_primary_10_1038_s41375_024_02173_2 crossref_primary_10_1002_pbc_26519 crossref_primary_10_1111_bjh_16773 crossref_primary_10_1111_bjh_14474 crossref_primary_10_1515_cclm_2018_0507 crossref_primary_10_1038_leu_2016_234 crossref_primary_10_1001_jamanetworkopen_2024_2727 crossref_primary_10_1124_pharmrev_124_001049 crossref_primary_10_3390_cancers13236064 crossref_primary_10_1182_blood_2018_04_845628 crossref_primary_10_3390_ijms21062193 crossref_primary_10_1016_j_bbrc_2019_01_064 crossref_primary_10_1007_s00432_019_02886_3 crossref_primary_10_1038_s41571_018_0136_6 crossref_primary_10_1111_bjh_15436 crossref_primary_10_1177_09603271251345656 crossref_primary_10_3390_biomedicines13061412 crossref_primary_10_3389_fonc_2023_1236129 crossref_primary_10_2217_fon_2017_0467 crossref_primary_10_1038_s41388_020_01567_7 crossref_primary_10_4103_ijmpo_ijmpo_6_16 crossref_primary_10_1016_j_toxlet_2024_08_010 crossref_primary_10_1111_ijlh_12835 crossref_primary_10_1136_jitc_2020_000896 crossref_primary_10_1002_cncr_34606 crossref_primary_10_1016_S2352_3026_17_30052_2 crossref_primary_10_3390_cancers12113421 crossref_primary_10_1016_j_jpeds_2018_07_039 crossref_primary_10_1038_s41375_023_02089_3 crossref_primary_10_1080_10428194_2020_1805739 crossref_primary_10_1016_j_ebiom_2019_08_071 crossref_primary_10_3389_fonc_2023_1117096 crossref_primary_10_1007_s00432_023_04937_2 crossref_primary_10_1038_s41375_023_01870_8 crossref_primary_10_1111_ajco_13756 crossref_primary_10_3389_fped_2021_807002 |
| ContentType | Journal Article |
| Copyright | 2015 by American Society of Clinical Oncology. |
| Copyright_xml | – notice: 2015 by American Society of Clinical Oncology. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1200/JCO.2014.59.1636 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1527-7755 |
| ExternalDocumentID | 26304874 |
| Genre | Historical Article Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: CA36401 – fundername: NCI NIH HHS grantid: U10 CA098413 – fundername: NCI NIH HHS grantid: R01 CA036401 – fundername: NCI NIH HHS grantid: U10 CA98413 – fundername: NCI NIH HHS grantid: U10 CA98543 – fundername: NIGMS NIH HHS grantid: U01 GM092666 – fundername: NCI NIH HHS grantid: R37 CA036401 – fundername: NCI NIH HHS grantid: P30 CA021765 – fundername: NIGMS NIH HHS grantid: P50 GM115279 – fundername: NIGMS NIH HHS grantid: U01 GM92666 |
| GroupedDBID | --- .55 0R~ 18M 2WC 34G 39C 4.4 53G 5GY 5RE 8F7 AARDX AAWTL AAYEP AAYOK ABJNI ABOCM ACGFO ACGFS ACGUR ADBBV AEGXH AENEX AIAGR ALMA_UNASSIGNED_HOLDINGS BAWUL BYPQX C45 CGR CS3 CUY CVF DIK EBS ECM EIF EJD F5P F9R FBNNL FD8 GX1 H13 HZ~ IH2 K-O KQ8 L7B LSO MJL N9A NPM O9- OK1 OVD OWW P2P QTD R1G RHI RLZ RUC SJN TEORI TR2 TWZ UDS VVN WH7 X7M YCJ YFH YQY 7X8 ABBLC |
| ID | FETCH-LOGICAL-c462t-3e90b814c3a62851c6caddaacf4dd3ba579c6c281b7f81b9f49df5ae0387315c2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 754 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000366018800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1527-7755 |
| IngestDate | Fri Sep 05 11:34:34 EDT 2025 Thu Apr 03 07:05:56 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 27 |
| Language | English |
| License | 2015 by American Society of Clinical Oncology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c462t-3e90b814c3a62851c6caddaacf4dd3ba579c6c281b7f81b9f49df5ae0387315c2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | http://doi.org/10.1200/JCO.2014.59.1636 |
| PMID | 26304874 |
| PQID | 1713952397 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1713952397 pubmed_primary_26304874 |
| PublicationCentury | 2000 |
| PublicationDate | 2015-09-20 |
| PublicationDateYYYYMMDD | 2015-09-20 |
| PublicationDate_xml | – month: 09 year: 2015 text: 2015-09-20 day: 20 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of clinical oncology |
| PublicationTitleAlternate | J Clin Oncol |
| PublicationYear | 2015 |
| References | 24246699 - Semin Hematol. 2013 Oct;50(4):314-24 19236609 - Br J Haematol. 2009 May;145(3):376-88 25710658 - JAMA. 2015 Feb 24;313(8):815-23 19838194 - Nat Genet. 2009 Nov;41(11):1243-6 22614971 - J Clin Oncol. 2012 Jul 1;30(19):2384-92 20016536 - Leukemia. 2010 Feb;24(2):255-64 22897847 - Cancer Cell. 2012 Aug 14;22(2):153-66 19129520 - N Engl J Med. 2009 Jan 29;360(5):470-80 15630450 - J Clin Invest. 2005 Jan;115(1):110-7 20592248 - Blood. 2010 Oct 14;116(15):2644-50 19965641 - Blood. 2010 Feb 4;115(5):1006-17 18502832 - Blood. 2008 Sep 1;112(5):1646-54 18565889 - J Clin Oncol. 2008 Jun 20;26(18):3031-7 24970932 - Blood. 2014 Aug 21;124(8):1266-76 22641210 - Nat Genet. 2012 Jun;44(6):619-22 23334668 - Nat Genet. 2013 Mar;45(3):242-52 17344859 - Nature. 2007 Apr 12;446(7137):758-64 21372841 - Leukemia. 2011 Jun;25(6):953-9 24550419 - J Clin Oncol. 2014 Mar 20;32(9):949-59 24727815 - Haematologica. 2014 Jul;99(7):1220-7 20010622 - Leukemia. 2010 Feb;24(2):345-54 22147369 - Genome Res. 2012 Jan;22(1):1-8 24708207 - Br J Haematol. 2014 Aug;166(3):421-4 12057554 - Lancet. 2002 Jun 1;359(9321):1909-15 12610173 - J Clin Oncol. 2003 Mar 1;21(5):774-80 18987654 - Leukemia. 2009 Mar;23(3):557-64 17473063 - Blood. 2007 Aug 15;110(4):1112-5 24449211 - Blood. 2014 Mar 27;123(13):2026-33 22412151 - J Clin Oncol. 2012 May 10;30(14):1663-9 21172890 - J Clin Oncol. 2011 Feb 1;29(4):386-91 19138562 - Lancet Oncol. 2009 Feb;10(2):125-34 23715577 - J Clin Oncol. 2013 Jul 1;31(19):2460-8 12682627 - Leukemia. 2003 Apr;17(4):700-6 20535816 - Pediatr Blood Cancer. 2010 Dec 15;55(7):1287-95 21946537 - Nat Med. 2011 Oct;17(10):1298-303 24687960 - J Exp Med. 2014 Apr 7;211(4):701-13 24013638 - Nat Genet. 2013 Oct;45(10):1226-31 24141364 - Nat Genet. 2013 Dec;45(12):1494-8 18285546 - Blood. 2008 May 1;111(9):4496-9 23461707 - Eur J Haematol. 2013 May;90(5):404-12 22117041 - Blood. 2012 Feb 16;119(7):1658-64 23138181 - Leukemia. 2013 Apr;27(4):866-70 15085155 - Leukemia. 2004 Jun;18(6):1043-53 19747876 - Lancet Oncol. 2009 Oct;10(10):957-66 23974192 - Blood. 2013 Oct 10;122(15):2622-9 20010625 - Leukemia. 2010 Feb;24(2):265-84 25049327 - J Clin Oncol. 2014 Sep 20;32(27):3012-20 22237106 - Nature. 2012 Jan 12;481(7380):157-63 21777205 - Ann Hum Genet. 2011 Sep;75(5):589-97 24470002 - J Clin Oncol. 2014 Mar 1;32(7):647-53 22494120 - N Engl J Med. 2012 Apr 12;366(15):1371-81 19641190 - Blood. 2009 Sep 24;114(13):2688-98 10749961 - N Engl J Med. 2000 Apr 6;342(14):998-1006 20335220 - Blood. 2010 Jun 10;115(23):4671-7 22076464 - Leukemia. 2012 May;26(5):902-9 1973780 - Lancet. 1990 Jul 28;336(8709):225-9 24176570 - Lancet Oncol. 2013 Nov;14(12):e508-23 16041371 - Nat Genet. 2005 Aug;37(8):878-82 20016530 - Leukemia. 2010 Feb;24(2):298-308 10580024 - J Natl Cancer Inst. 1999 Dec 1;91(23):2001-8 24186319 - Haematologica. 2013 Nov;98(11):e146-8 19901119 - J Clin Oncol. 2009 Dec 10;27(35):5972-8 19684603 - Nat Genet. 2009 Sep;41(9):1001-5 22898679 - Lancet Oncol. 2012 Sep;13(9):936-45 24222333 - Blood. 2014 Jan 2;123(1):70-7 21481790 - Cancer Cell. 2011 Apr 12;19(4):484-97 23358966 - J Clin Oncol. 2013 Mar 20;31(9):1202-10 22441210 - Leukemia. 2012 Oct;26(10):2204-11 19470474 - Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9414-8 24781017 - Leukemia. 2014 Dec;28(12):2336-43 23835704 - J Clin Oncol. 2013 Sep 1;31(25):e413-6 15784872 - JAMA. 2005 Mar 23;293(12):1485-9 20331462 - Br J Haematol. 2010 Jun;149(5):722-33 24990611 - Leukemia. 2015 Feb;29(2):297-303 21719599 - Blood. 2011 Aug 25;118(8):2077-84 24441288 - Leukemia. 2014 Jul;28(7):1467-71 10029593 - Blood. 1999 Mar 1;93(5):1643-50 24344215 - J Clin Oncol. 2014 Jan 20;32(3):174-84 17658395 - Lancet. 2007 Jul 21;370(9583):240-50 20154213 - Blood. 2010 Apr 22;115(16):3206-14 25624441 - J Clin Oncol. 2015 Apr 10;33(11):1235-42 23024117 - Pediatr Blood Cancer. 2013 Feb;60(2):344-8 18416598 - PLoS Med. 2008 Apr 15;5(4):e83 25207766 - N Engl J Med. 2014 Sep 11;371(11):1005-15 20453839 - Nat Genet. 2010 Jun;42(6):492-4 22693038 - Pediatr Blood Cancer. 2013 Feb;60(2):185-95 15295046 - N Engl J Med. 2004 Aug 5;351(6):533-42 19684604 - Nat Genet. 2009 Sep;41(9):1006-10 20876426 - J Clin Oncol. 2010 Nov 1;28(31):4755-61 19176441 - JAMA. 2009 Jan 28;301(4):393-403 23233662 - Blood. 2013 Feb 7;121(6):898-904 24821882 - J Clin Oncol. 2014 Jun 10;32(17):1825-9 20145664 - Leukemia. 2010 Feb;24(2):253-4 15459215 - J Clin Oncol. 2004 Oct 1;22(19):3930-6 11304783 - J Clin Oncol. 2001 Apr 15;19(8):2293-301 23996088 - Blood. 2013 Nov 7;122(19):3298-307 24924991 - Lancet Oncol. 2014 Jul;15(8):809-18 15837626 - Cancer Cell. 2005 Apr;7(4):375-86 20824725 - Cancer. 2011 Jan 15;117(2):238-49 19147408 - Lancet Oncol. 2009 Feb;10(2):147-56 23512250 - J Natl Cancer Inst. 2013 May 15;105(10):733-42 |
| References_xml | – reference: 15630450 - J Clin Invest. 2005 Jan;115(1):110-7 – reference: 23715577 - J Clin Oncol. 2013 Jul 1;31(19):2460-8 – reference: 20824725 - Cancer. 2011 Jan 15;117(2):238-49 – reference: 23024117 - Pediatr Blood Cancer. 2013 Feb;60(2):344-8 – reference: 20016536 - Leukemia. 2010 Feb;24(2):255-64 – reference: 12610173 - J Clin Oncol. 2003 Mar 1;21(5):774-80 – reference: 18502832 - Blood. 2008 Sep 1;112(5):1646-54 – reference: 22076464 - Leukemia. 2012 May;26(5):902-9 – reference: 20154213 - Blood. 2010 Apr 22;115(16):3206-14 – reference: 24687960 - J Exp Med. 2014 Apr 7;211(4):701-13 – reference: 23996088 - Blood. 2013 Nov 7;122(19):3298-307 – reference: 24924991 - Lancet Oncol. 2014 Jul;15(8):809-18 – reference: 24013638 - Nat Genet. 2013 Oct;45(10):1226-31 – reference: 22147369 - Genome Res. 2012 Jan;22(1):1-8 – reference: 20331462 - Br J Haematol. 2010 Jun;149(5):722-33 – reference: 22897847 - Cancer Cell. 2012 Aug 14;22(2):153-66 – reference: 23461707 - Eur J Haematol. 2013 May;90(5):404-12 – reference: 19147408 - Lancet Oncol. 2009 Feb;10(2):147-56 – reference: 24708207 - Br J Haematol. 2014 Aug;166(3):421-4 – reference: 21719599 - Blood. 2011 Aug 25;118(8):2077-84 – reference: 24449211 - Blood. 2014 Mar 27;123(13):2026-33 – reference: 24550419 - J Clin Oncol. 2014 Mar 20;32(9):949-59 – reference: 15085155 - Leukemia. 2004 Jun;18(6):1043-53 – reference: 17344859 - Nature. 2007 Apr 12;446(7137):758-64 – reference: 17658395 - Lancet. 2007 Jul 21;370(9583):240-50 – reference: 24781017 - Leukemia. 2014 Dec;28(12):2336-43 – reference: 18285546 - Blood. 2008 May 1;111(9):4496-9 – reference: 17473063 - Blood. 2007 Aug 15;110(4):1112-5 – reference: 23835704 - J Clin Oncol. 2013 Sep 1;31(25):e413-6 – reference: 22412151 - J Clin Oncol. 2012 May 10;30(14):1663-9 – reference: 15784872 - JAMA. 2005 Mar 23;293(12):1485-9 – reference: 24141364 - Nat Genet. 2013 Dec;45(12):1494-8 – reference: 19684603 - Nat Genet. 2009 Sep;41(9):1001-5 – reference: 19138562 - Lancet Oncol. 2009 Feb;10(2):125-34 – reference: 23512250 - J Natl Cancer Inst. 2013 May 15;105(10):733-42 – reference: 24990611 - Leukemia. 2015 Feb;29(2):297-303 – reference: 22693038 - Pediatr Blood Cancer. 2013 Feb;60(2):185-95 – reference: 10029593 - Blood. 1999 Mar 1;93(5):1643-50 – reference: 21481790 - Cancer Cell. 2011 Apr 12;19(4):484-97 – reference: 21946537 - Nat Med. 2011 Oct;17(10):1298-303 – reference: 22898679 - Lancet Oncol. 2012 Sep;13(9):936-45 – reference: 19176441 - JAMA. 2009 Jan 28;301(4):393-403 – reference: 20592248 - Blood. 2010 Oct 14;116(15):2644-50 – reference: 10580024 - J Natl Cancer Inst. 1999 Dec 1;91(23):2001-8 – reference: 20145664 - Leukemia. 2010 Feb;24(2):253-4 – reference: 18416598 - PLoS Med. 2008 Apr 15;5(4):e83 – reference: 23358966 - J Clin Oncol. 2013 Mar 20;31(9):1202-10 – reference: 24821882 - J Clin Oncol. 2014 Jun 10;32(17):1825-9 – reference: 15459215 - J Clin Oncol. 2004 Oct 1;22(19):3930-6 – reference: 19684604 - Nat Genet. 2009 Sep;41(9):1006-10 – reference: 19129520 - N Engl J Med. 2009 Jan 29;360(5):470-80 – reference: 19747876 - Lancet Oncol. 2009 Oct;10(10):957-66 – reference: 20876426 - J Clin Oncol. 2010 Nov 1;28(31):4755-61 – reference: 19965641 - Blood. 2010 Feb 4;115(5):1006-17 – reference: 19236609 - Br J Haematol. 2009 May;145(3):376-88 – reference: 21172890 - J Clin Oncol. 2011 Feb 1;29(4):386-91 – reference: 16041371 - Nat Genet. 2005 Aug;37(8):878-82 – reference: 18987654 - Leukemia. 2009 Mar;23(3):557-64 – reference: 24222333 - Blood. 2014 Jan 2;123(1):70-7 – reference: 25049327 - J Clin Oncol. 2014 Sep 20;32(27):3012-20 – reference: 24176570 - Lancet Oncol. 2013 Nov;14(12):e508-23 – reference: 24344215 - J Clin Oncol. 2014 Jan 20;32(3):174-84 – reference: 1973780 - Lancet. 1990 Jul 28;336(8709):225-9 – reference: 25710658 - JAMA. 2015 Feb 24;313(8):815-23 – reference: 22641210 - Nat Genet. 2012 Jun;44(6):619-22 – reference: 21372841 - Leukemia. 2011 Jun;25(6):953-9 – reference: 23974192 - Blood. 2013 Oct 10;122(15):2622-9 – reference: 24441288 - Leukemia. 2014 Jul;28(7):1467-71 – reference: 24970932 - Blood. 2014 Aug 21;124(8):1266-76 – reference: 19901119 - J Clin Oncol. 2009 Dec 10;27(35):5972-8 – reference: 24186319 - Haematologica. 2013 Nov;98(11):e146-8 – reference: 19641190 - Blood. 2009 Sep 24;114(13):2688-98 – reference: 20010622 - Leukemia. 2010 Feb;24(2):345-54 – reference: 21777205 - Ann Hum Genet. 2011 Sep;75(5):589-97 – reference: 20016530 - Leukemia. 2010 Feb;24(2):298-308 – reference: 12057554 - Lancet. 2002 Jun 1;359(9321):1909-15 – reference: 25207766 - N Engl J Med. 2014 Sep 11;371(11):1005-15 – reference: 22494120 - N Engl J Med. 2012 Apr 12;366(15):1371-81 – reference: 23138181 - Leukemia. 2013 Apr;27(4):866-70 – reference: 22614971 - J Clin Oncol. 2012 Jul 1;30(19):2384-92 – reference: 23233662 - Blood. 2013 Feb 7;121(6):898-904 – reference: 10749961 - N Engl J Med. 2000 Apr 6;342(14):998-1006 – reference: 19470474 - Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9414-8 – reference: 19838194 - Nat Genet. 2009 Nov;41(11):1243-6 – reference: 22117041 - Blood. 2012 Feb 16;119(7):1658-64 – reference: 22441210 - Leukemia. 2012 Oct;26(10):2204-11 – reference: 15837626 - Cancer Cell. 2005 Apr;7(4):375-86 – reference: 12682627 - Leukemia. 2003 Apr;17(4):700-6 – reference: 20335220 - Blood. 2010 Jun 10;115(23):4671-7 – reference: 23334668 - Nat Genet. 2013 Mar;45(3):242-52 – reference: 24470002 - J Clin Oncol. 2014 Mar 1;32(7):647-53 – reference: 20453839 - Nat Genet. 2010 Jun;42(6):492-4 – reference: 11304783 - J Clin Oncol. 2001 Apr 15;19(8):2293-301 – reference: 24246699 - Semin Hematol. 2013 Oct;50(4):314-24 – reference: 18565889 - J Clin Oncol. 2008 Jun 20;26(18):3031-7 – reference: 20010625 - Leukemia. 2010 Feb;24(2):265-84 – reference: 22237106 - Nature. 2012 Jan 12;481(7380):157-63 – reference: 25624441 - J Clin Oncol. 2015 Apr 10;33(11):1235-42 – reference: 15295046 - N Engl J Med. 2004 Aug 5;351(6):533-42 – reference: 20535816 - Pediatr Blood Cancer. 2010 Dec 15;55(7):1287-95 – reference: 24727815 - Haematologica. 2014 Jul;99(7):1220-7 |
| SSID | ssj0014835 |
| Score | 2.6631238 |
| SecondaryResourceType | review_article |
| Snippet | To review the impact of collaborative studies on advances in the biology and treatment of acute lymphoblastic leukemia (ALL) in children and adolescents.
A... To review the impact of collaborative studies on advances in the biology and treatment of acute lymphoblastic leukemia (ALL) in children and... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 2938 |
| SubjectTerms | Adolescent Age of Onset Biomarkers, Tumor - genetics Child Child, Preschool Cooperative Behavior Diffusion of Innovation Genetic Predisposition to Disease Genetic Testing History, 20th Century History, 21st Century Humans Infant Infant, Newborn Interdisciplinary Communication International Cooperation Medical Oncology - trends Pediatrics - trends Phenotype Precision Medicine Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy Predictive Value of Tests Survivors Time Factors Treatment Outcome |
| Title | Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/26304874 https://www.proquest.com/docview/1713952397 |
| Volume | 33 |
| WOSCitedRecordID | wos000366018800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA_qRLz4Mb_mFxFkp3Vb26RpvMgYDpFt9jBht5KmCQyxnXYT9t_70nbWiyB4yaEloeS9vP7eR94PoVumBOHdiFhSmdCN0NzyPR1bsVKUa9OSLtI52QQbj_3plAdlwC0ryyrXNjE31HEqTYy8Y4M3xcFr4ux-_m4Z1iiTXS0pNDZRzYXXRqvZtMoiED8n2DTMrYAiKS3TlKAYnaf-s6nrIm3K2wBJvN8BZv6jGez_9xMP0F4JMXGv0IlDtKGSOtoZlUn0OmoGRbvqVQtPqttXWQs3cVA1sl4docF332Pck8uFwsMVyD6NAHDDBDxUy1f1NhN3ODBFXmAyYb2c9Qf3f2rXMXoZPEz6j1bJu2BJ4jkLy1UgPd8m0hXmgqUtPQlWUAipSRy7kaCMwyMHAC_TMHBNeKypUCYT7tpUOidoK0kTdYYwuIsgGM9zuPaJdCKhGdFcEljNuEKigW7WWxmCXptkhUhUuszCajMb6LSQRzgvGnCEjueC4WHk_A-zL9AuyJmaEg-ne4lqGk61ukLb8nMxyz6uc4WBcRyMvgB0m8uM |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Childhood+Acute+Lymphoblastic+Leukemia%3A+Progress+Through+Collaboration&rft.jtitle=Journal+of+clinical+oncology&rft.au=Pui%2C+Ching-Hon&rft.au=Yang%2C+Jun+J&rft.au=Hunger%2C+Stephen+P&rft.au=Pieters%2C+Rob&rft.date=2015-09-20&rft.issn=1527-7755&rft.eissn=1527-7755&rft.volume=33&rft.issue=27&rft.spage=2938&rft_id=info:doi/10.1200%2FJCO.2014.59.1636&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-7755&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-7755&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-7755&client=summon |